Howard Bradley Schiller, EVP and CFO at Valeant Pharmaceuticals International, Inc. (VRX), bought 11,000 shares at $45.51 ($501K) on 2011-12-08, disclosed to the SEC on 2011-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRX | BUY | 2012-03-05 | $998K | — | Filing → |
| VRX | BUY | 2011-12-07 | $515K | — | Filing → |
| VRX | BUY | 2011-12-05 | $1.5M | — | Filing → |